| Active Ingredient | ALPROSTADIL |
| Therapeutic Class | VASODILATING AGENTS, MISCELLANEOUS |
| Indications | Congenital heart disease in neonates until surgery is possible. |
| Caution | Infants: apnoea, fever, flushing, hypotension, bradycardia, tachycardia, diarrhoea, and convulsions. |
| Dose Range | Pediatric: Continuous intravenous infusion, initially 5 nanograms /kg/ minute, adjusted according to response, adjusted in steps of 5 nanograms/ kg / minute ( max . Per dose 100 nanograms /kg/minute), |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |